NERV

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total revenue 26.58 M10.38 K-8 376-21.11 K-6 246 -25.35 K Gross profit 26.58 M10.38 K-8 376-21.11 K-6 246 -25.35 K Operating expenses 4.37 M4.52 M3.9 M3.37 M2.84 M 14.64 M Selling/general/admin expenses 2.48 M2.54 M2.54 M2.08 M1.92 M 9.07 M Research & development 1.89 M1.98 M1.36 M1.3 M925.38 K 5.57 M Operating income -4.37 M-4.52 M-3.9 M-3.37 M-2.84 M -14.64 M Non-Operating Income, Total 300.86 K250.11 K149.91 K115.56 K100.39 K 615.97 K Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 300.86 K250.11 K149.91 K115.56 K100.39 K 615.97 K Unusual income/expense ————— — Pretax income -4.07 M-4.27 M-3.75 M-3.26 M-2.74 M -14.03 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 22.51 M-4.27 M-3.75 M-3.26 M-2.74 M -14.03 M Discontinued operations ————— — Net income 22.51 M-4.27 M-3.75 M-3.26 M-2.74 M -14.03 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 22.51 M-4.27 M-3.75 M-3.26 M-2.74 M -14.03 M Basic earnings per share (Basic EPS) 2.97-0.56-0.5-0.43-0.36 -1.85 Diluted earnings per share (Diluted EPS) 2.97-0.56-0.5-0.43-0.36 -1.85 Average basic shares outstanding 7.57 M7.57 M7.57 M7.57 M7.57 M 30.28 M Diluted shares outstanding 7.57 M7.57 M7.57 M7.57 M7.57 M 30.28 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —